Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

Daniel Morales-Cano; Jose Luis Izquierdo-García; Bianca Barreira; Sergio Esquivel-Ruiz; Maria Callejo; Rachele Pandolfi; Palmira Villa-Valverde; Ignacio Rodríguez; Angel Cogolludo; Jesus Ruiz-Cabello; Francisco Perez-Vizcaino; Laura Moreno

doi:10.3389/fphar.2023.1228923

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

Front Pharmacol. 2023 Jun 12:14:1228923. doi: 10.3389/fphar.2023.1228923. eCollection 2023.

Authors

Daniel Morales-Cano^{1

2

3

4

5}, Jose Luis Izquierdo-García^{2

6

7}, Bianca Barreira^{1

2

3}, Sergio Esquivel-Ruiz^{1

2

3}, Maria Callejo^{1

2

3}, Rachele Pandolfi^{1

2

3}, Palmira Villa-Valverde^{2

8}, Ignacio Rodríguez^{2

6}, Angel Cogolludo^{1

2

3}, Jesus Ruiz-Cabello^{2

6

9}, Francisco Perez-Vizcaino^{1

2

3}, Laura Moreno^{1

2

3}

Affiliations

¹ Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
² Ciber Enfermedades Respiratorias (Ciberes), Madrid, Spain.
³ Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
⁴ Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
⁵ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁶ Department of Chemistry in Pharmaceutical Sciences, School of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain.
⁷ Instituto Pluridisciplinar, Universidad Complutense de Madrid, Madrid, Spain.
⁸ ICTS Bioimagen Complutense, Universidad Complutense de Madrid, Madrid, Spain.
⁹ Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Donostia San Sebastián, Spain.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1021535.].

Keywords: antiproliferative; combination therapy; metabolomics; pulmonary hypertension; right ventricle.

Publication types

Published Erratum